Specific and nonspecific mediation of protective immunity to Toxoplasma gondii - PubMed (original) (raw)
Specific and nonspecific mediation of protective immunity to Toxoplasma gondii
L Reyes et al. Infect Immun. 1987 Apr.
Abstract
We studied the specificity of protection conferred by Toxoplasma gondii immune lymphocytes and their supernatants on infected hamster kidney cells, using Besnoitia jellisoni immune lymphocytes as a nonspecific control. The intracellular growth of the organisms was measured by [3H]uracil incorporation, and inhibition of multiplication was used as a measurement of immunity. Although the immune lymphocytes restricted principally the multiplication of homologous organisms, partial protection, expressed against the heterologous organism, was found. This was true for either parasite with intact lymphocytes or their supernatants. Exposure of immune lymphocytes to antigen for 18 to 24 h and treatment of kidney cells with supernatant fluids for 18 to 24 h were required for maximal protection. The specific protective mediator in supernatants of immune lymphocytes was characterized by dialysis as having a molecular weight between 3,000 and 12,000 and was found in the 3,000 to 5,000 peak after Sephadex G-50 chromatography. Nonspecific protective activity was greater than 12,000 by dialysis; it chromatographed in the excluded peak, measuring over 43,000, and was destroyed by exposure to pH 2. In vitro production of lymphokines from toxoplasma immune lymphocytes was first detected 7 to 10 days after vaccination of hamsters. At about the same time, hamsters began to resist challenge infection with the pathogenic RH strain of T. gondii and were able to prevent its multiplication in lungs, liver, spleen, and the subcutaneous infection site. The expression of tissue immunity and the production of toxoplasma-immune lymphokines appear to be time-related events.
Similar articles
- Cell-mediated immunity against Besnoitia and toxoplasma in specifically and cross-immunized hamsters and in cultures.
Hoff RL, Frenkel JK. Hoff RL, et al. J Exp Med. 1974 Mar 1;139(3):560-80. doi: 10.1084/jem.139.3.560. J Exp Med. 1974. PMID: 4812629 Free PMC article. - Specific mediation of cellular immunity to Toxoplasma gondii in somatic cells of mice.
Chinchilla M, Frenkel JK. Chinchilla M, et al. Infect Immun. 1984 Dec;46(3):862-6. doi: 10.1128/iai.46.3.862-866.1984. Infect Immun. 1984. PMID: 6500716 Free PMC article. - Strain- and Dose-Dependent Reduction of Toxoplasma gondii Burden in Pigs Is Associated with Interferon-Gamma Production by CD8+ Lymphocytes in a Heterologous Challenge Model.
Jennes M, De Craeye S, Devriendt B, Dierick K, Dorny P, Cox E. Jennes M, et al. Front Cell Infect Microbiol. 2017 Jun 8;7:232. doi: 10.3389/fcimb.2017.00232. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28642841 Free PMC article. - Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review.
Faridnia R, Daryani A, Sarvi S, Sharif M, Kalani H. Faridnia R, et al. Comp Immunol Microbiol Infect Dis. 2018 Aug;59:32-40. doi: 10.1016/j.cimid.2018.09.005. Epub 2018 Sep 14. Comp Immunol Microbiol Infect Dis. 2018. PMID: 30290885 Review. - Recent advances in developing vaccines against Toxoplasma gondii: an update.
Zhang NZ, Wang M, Xu Y, Petersen E, Zhu XQ. Zhang NZ, et al. Expert Rev Vaccines. 2015;14(12):1609-21. doi: 10.1586/14760584.2015.1098539. Epub 2015 Oct 14. Expert Rev Vaccines. 2015. PMID: 26467840 Review.
Cited by
- Immunization of BALB/c Mice with Killed Tachyzoites of Toxoplasma gondii against Acute Toxoplasmosis.
Guo HT, Tan J, He YL, Li X, Liang X, Li ZY. Guo HT, et al. Iran J Parasitol. 2023 Oct-Dec;18(4):435-444. doi: 10.18502/ijpa.v18i4.14243. Iran J Parasitol. 2023. PMID: 38169648 Free PMC article. - Protective role for interleukin-5 during chronic Toxoplasma gondii infection.
Zhang Y, Denkers EY. Zhang Y, et al. Infect Immun. 1999 Sep;67(9):4383-92. doi: 10.1128/IAI.67.9.4383-4392.1999. Infect Immun. 1999. PMID: 10456878 Free PMC article. - Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.
Denkers EY, Gazzinelli RT. Denkers EY, et al. Clin Microbiol Rev. 1998 Oct;11(4):569-88. doi: 10.1128/CMR.11.4.569. Clin Microbiol Rev. 1998. PMID: 9767056 Free PMC article. Review. - Human T-cell clones against Toxoplasma gondii: production of interferon-gamma, interleukin-2, and strain cross-reactivity.
Saavedra R, Hérion P. Saavedra R, et al. Parasitol Res. 1991;77(5):379-85. doi: 10.1007/BF00931632. Parasitol Res. 1991. PMID: 1679934
References
- J Immunol. 1973 Dec;111(6):1914-22 - PubMed
- Adv Immunol. 1982;33:73-166 - PubMed
- J Exp Med. 1975 Feb 1;141(2):483-96 - PubMed
- Exp Parasitol. 1983 Jun;55(3):320-30 - PubMed
- J Immunol. 1983 Aug;131(2):833-44 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources